BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31778852)

  • 1. Efficacy of gamithromycin injection administered intramuscularly against bacterial swine respiratory disease.
    Xiao T; Yang Y; Zhang Y; Cheng P; Yu H; Liu R; Ishfaq M; Zhang X
    Res Vet Sci; 2020 Feb; 128():118-123. PubMed ID: 31778852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of tulathromycin injectable solution for the treatment of naturally occurring Swine respiratory disease.
    Nutsch RG; Hart FJ; Rooney KA; Weigel DJ; Kilgore WR; Skogerboe TL
    Vet Ther; 2005; 6(2):214-24. PubMed ID: 16094568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamithromycin in swine: Pharmacokinetics and clinical evaluation against swine respiratory disease.
    Hamel D; Richard-Mazet A; Voisin F; Böhne I; Fraisse F; Rauh R; Huang R; Kellermann M; Letendre L; Dumont P; Rehbein S
    Vet Med Sci; 2021 Mar; 7(2):455-464. PubMed ID: 33058489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the therapeutic activity of tulathromycin against swine respiratory disease on farms in Europe.
    Nanjiani IA; McKelvie J; Benchaoui HA; Godinho KS; Sherington J; Sunderland SJ; Weatherley AJ; Rowan TG
    Vet Ther; 2005; 6(2):203-13. PubMed ID: 16094567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.
    Blondeau JM; Fitch SD
    PLoS One; 2019; 14(1):e0210154. PubMed ID: 30629633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bordetella bronchiseptica experimental model development in pigs and efficacy evaluation of a single intramuscular injection of gamithromycin (Zactran® for Swine) against Bordetella bronchiseptica-associated respiratory disease in experimentally infected piglets.
    Gupta A; Cortes-Dubly ML; Buellet P; Richard-Mazet A; Merdy O; Targa NL; Dumont P
    J Vet Pharmacol Ther; 2020 Mar; 43(2):197-207. PubMed ID: 31872885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance genes in Actinobacillus pleuropneumoniae, Haemophilus parasuis and Pasteurella multocida isolated from Australian pigs.
    Dayao D; Gibson JS; Blackall PJ; Turni C
    Aust Vet J; 2016 Jul; 94(7):227-31. PubMed ID: 27349882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole Genome Sequence Analysis of Pig Respiratory Bacterial Pathogens with Elevated Minimum Inhibitory Concentrations for Macrolides.
    Dayao DA; Seddon JM; Gibson JS; Blackall PJ; Turni C
    Microb Drug Resist; 2016 Oct; 22(7):531-537. PubMed ID: 26981707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of antimicrobial susceptibility of respiratory tract pathogens isolated from diseased cattle and pigs across Europe, 2009-2012: VetPath results.
    El Garch F; de Jong A; Simjee S; Moyaert H; Klein U; Ludwig C; Marion H; Haag-Diergarten S; Richard-Mazet A; Thomas V; Siegwart E
    Vet Microbiol; 2016 Oct; 194():11-22. PubMed ID: 27102206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility monitoring of respiratory tract pathogens isolated from diseased cattle and pigs across Europe: the VetPath study.
    de Jong A; Thomas V; Simjee S; Moyaert H; El Garch F; Maher K; Morrissey I; Butty P; Klein U; Marion H; Rigaut D; Vallé M
    Vet Microbiol; 2014 Aug; 172(1-2):202-15. PubMed ID: 24837878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of tulathromycin in the treatment of respiratory disease in pigs caused by Actinobacillus pleuropneumoniae.
    Hart FJ; Kilgore RW; Meinert TR; Nutsch RG; Sunderland SJ; Lechtenberg KF
    Vet Rec; 2006 Apr; 158(13):433-6. PubMed ID: 16581993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Actinobacillus pleuropneumoniae, Actinobacillus suis, Haemophilus parasuis, Pasteurella multocida, and Streptococcus suis in representative Ontario swine herds.
    MacInnes JI; Gottschalk M; Lone AG; Metcalf DS; Ojha S; Rosendal T; Watson SB; Friendship RM
    Can J Vet Res; 2008 Apr; 72(3):242-8. PubMed ID: 18505187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets.
    Zhou YF; Bu MX; Liu P; Sun J; Liu YH; Liao XP
    BMC Vet Res; 2020 Mar; 16(1):81. PubMed ID: 32138735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of a new 450 mg/ml florfenicol formulation administered intramuscularly in the treatment of bacterial bovine respiratory disease.
    Thiry J; Rubion S; Sarasola P; Bonnier M; Hartmann M; de Haas V
    Vet Rec; 2011 Nov; 169(20):526. PubMed ID: 21921060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of porcine respiratory pathogens to tilmicosin.
    DeRosa DC; Veenhuizen MF; Bade DJ; Shryock TR
    J Vet Diagn Invest; 2000 Nov; 12(6):541-6. PubMed ID: 11108454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility testing of tulathromycin: interpretative breakpoints and susceptibility of field isolates.
    Godinho KS
    Vet Microbiol; 2008 Jun; 129(3-4):426-32. PubMed ID: 18187275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimum inhibitory concentrations of tulathromycin against respiratory bacterial pathogens isolated from clinical cases in European cattle and swine and variability arising from changes in in vitro methodology.
    Godinho KS; Keane SG; Nanjiani IA; Benchaoui HA; Sunderland SJ; Jones MA; Weatherley AJ; Gootz TD; Rowan TG
    Vet Ther; 2005; 6(2):113-21. PubMed ID: 16094559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tulathromycin on the carrier status of Actinobacillus pleuropneumoniae serotype 2 in the tonsils of pigs.
    Angen Ø; Andreasen M; Nielsen EO; Stockmarr A; Baekbo P
    Vet Rec; 2008 Oct; 163(15):445-7. PubMed ID: 18849576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic/pharmacodynamic evaluation of gamithromycin against rabbit pasteurellosis.
    Wei XY; Zhang J; Zhang Y; Fu WZ; Zhong LG; Pan YD; Sun J; Liao XP; Liu YH; Zhou YF
    BMC Vet Res; 2024 Apr; 20(1):147. PubMed ID: 38643185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical field trials with tilmicosin phosphate in feed for the control of naturally acquired pneumonia caused by Actinobacillus pleuropneumoniae and Pasteurella multocida in swine.
    Moore GM; Basson RP; Tonkinson LV
    Am J Vet Res; 1996 Feb; 57(2):224-8. PubMed ID: 8633813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.